Assessment of proliferating cell nuclear antigen activity using digital image analysis in breast carcinoma following magnetic resonance-guided interstitial laser photocoagulation

Breast Journal

Volumn 9, Issue 5, 2003, Pages 409-413

  Korourian, Soheila ^a   Klimberg, Suzanne ^a   Henry Tillman, Rhonda ^a   Lindquist, Diana ^a   Jones, Mary ^a   Eng, David Cardwell ^a   Helsel, Jay C ^a   Mumtaz, Hameed ^a   Westbrook, Kent ^a   Harms, Steven ^a  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

Breast neoplasm; Laser treatment; MRI; PCNA

Indexed keywords

CYCLINE;

ADULT; AGED; ARTICLE; BREAST CARCINOMA; CANCER DIAGNOSIS; CANCER PATIENT; CANCER STAGING; CELL PROLIFERATION; CLINICAL ARTICLE; FEMALE; HUMAN; IMAGE ANALYSIS; IMMUNOHISTOCHEMISTRY; IMMUNOPEROXIDASE STAINING; LASER COAGULATION; NUCLEAR MAGNETIC RESONANCE IMAGING; PARTIAL MASTECTOMY; RISK ASSESSMENT; TUMOR VOLUME;

ADULT; AGED; BIOPSY; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; FEMALE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; IMMUNOHISTOCHEMISTRY; LASER COAGULATION; MAGNETIC RESONANCE IMAGING; MIDDLE AGED; PROLIFERATING CELL NUCLEAR ANTIGEN;

EID: 10744230094     PISSN: 1075122X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1524-4741.2003.09509.x     Document Type: Article

References (29)

1. American Cancer Society. Cancer statistics 2000. CA Cancer J Clin 2000;50:7-33.
2. Rosen PP, Groshen S, Saigo PE, Kinne DW, Hellman S. A long term follow-up study of survival in stage I (T1N0M0) and stage II (T1N1M0) breast carcinoma. J Clin Oncol 1989;7:355-66.
3. Joensuu H, Taikkanen S. Cured of breast cancer. J Clin Oncol 1995;13:62-69.
4. Letton AH, Mason EM, Ramshaw BJ. Twenty year review of a breast cancer screening project ninety-five percent survival of patients with nonpalpable cancer. Cancer 1996;77:104-6.
5. Leitner SP, Swern AS, Weinberger D, Duncan LJ, Hetter RVP. Predictors of recurrence for patients with small (one centimeter or less) localized breast cancer (T1a, b N0, M0). Cancer 1989;64:1074-1081.
6. Cady B. Choice of operations for early breast cancer: an expanding role for breast conservation instead of mastectomy. In: Bland KI, Copeland EM III, eds. The Breast: Comprehensive Management of Benign and Malignant Diseases, 2nd ed. Philadelphia: WB Saunders, 1998:1130-52.
7. Harms SE, Flamig DP, Hesley KL, et al. Breast MRI: rotating delivery of excitation off-resonance: clinical experience with pathologic correlations. Radiology 1993;87:493-501.
8. Harms SE, Flaming DP. MR imaging of the breast: technical approach and clinical experience. Radiographics 1993;13:905-12.
9. Cross MJ, Harms SE, Cheek JH, Peters GN, Jones RC. New horizons in the diagnosis and treatment of breast cancer using magnetic resonance imaging. Am J Surg 1993;166:749-55.
10. Harms SE, Flamig DP, Hesley KL, et al. Fat suppressed three-dimensional MR imaging of the breast. Radiographics 1993;13:247-67.
11. Abraham DC, Jones RC, Jones SE, et al. Magnetic resonance imaging. Cancer 1996;78:91-100.
12. Harms SE, Jensen RA, Meiches MD, Flamig DP, Evans WP. Silicone-suppressed 3D MRI of the breast using rotating delivery of excitation off-resonance. Comput Assist Tomogr 1995;19:394.
13. Harms SE, Flamig DP, Evans WP, et al. Magnetic resonance imaging of the breast: present and future roles. Baylor Proc 1994;7:21-26.
14. Pierce WB, Harms SE, Flamig DP, Griffey RH, Evans WP, Hagans JE. Gd-DTPA enhanced MR imaging of the breast: a new fat suppressed three-dimensional imaging sequence. Radiology 1991;181:757-63.
15. Rodenko GN, Harms SE, Farrell RS, et al. MR imaging in the management before surgery of lobular carcinoma of the breast: comparison with pathology. AJR Am J Roentgenol 1996;167:1415.
16. Sonderstrom CE, Harms SE, Farrell RS, et al. MRI assessment of residual breast cancer post-lumpectomy. AJR Am J Roentgenol 1997;168:485-88.
17. Harms SE, Flamig DP. Staging of breast cancer with magnetic resonance. MRI Clin N Am 1994;2:40.
18. Harms SE. Integration of breast magnetic resonance imaging with breast cancer treatment. Top Magn Reson Imaging 1998;9:79-91.
19. Mumtaz H, Hall-Craggs MA, Wotherspoon A, et al. Laser therapy for breast cancer: MR imaging and histopathologic correlation. Radiology 1996;200:651-58.
20. Guglielmi R, Pacella CM, Dottorini ME, et al. Severe thyrotoxicosis due to hyperfunctioning liver metastasis from follicular carcinoma: treatment with (131)I and interstitial laser ablation. Thyroid 1999;9:173-77.
21. Mack MG, Straub R, Eichler K, Engelmann K, Roggan A, Vogl TJ. MR-guided laser-induced thermotherapy (LITT) of liver metastases: indications, complications, imaging criteria and local tumor control rate: experience after 2138 laser applications in 822 metastases. Proc Int Soc Magn Reson Med 1999;7:1944.
22. Lanzafame RJ. Applications of laser technology in breast cancer therapy. Semin Surg Oncol 1995;11:328-32.
23. Storm FK, Sliberman AW, Ramming KR, et al. Clinical thermochemotherapy: a controlled trial in advanced cancer patients. Cancer 1984;53:863-68.
24. Steger AC, Lees WR, Walmsley K, Bown SG. Interstitial laser hyperthermia: a new approach to local destruction of tumors. Br Med J 1989;299:362-65.
25. Kahn T, Bettag M, Ulrich F, et al. MRI-guided laser-induced interstitial thermotherapy of cerebral neoplasms. J Comput Assist Tomogr 1994;18:519-32.
26. Amin Z, Donaid JJ, Masters A, et al. Hepatic metastases: interstitial laser photocoagulation with real-time US monitoring and dynamic CT evaluation of treatment. Radiology 1993;187:339-47.
27. Jacques SL, Rastegar S, Motamedi M, et al. Liver photocoagulation with diode laser (805 nm) vs Nd:YAG laser (1064 nm). Proc SPIE 1992;1646:107-17.
28. Pascucci B, Stucki M, Jonsson ZO, Doglioti E, Huebscher U. Long patch base excision repair with purified human proteins. DNA ligase I as a patch size mediator for DNA polymerase delta and epsilon. J Biol Chem 1999;274:33696-702.
29. 2 in rat neuronal PC12 cell. Nucleic Acids Res 2000;28:2135-40.